Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Misses Revenue Estimates

Clearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of 11.11% and -7.30%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for…